Bioxcel Therapeutics (BX20) Cash flow

10 Followers

Bioxcel Therapeutics Cash Flow

DE:BX20's free cash flow for Q2 2026 was $-6.10M. For the 2026 fiscal year, DE:BX20's free cash flow was decreased by $14.41M and operating cash flow was $-6.10M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -57.62M	$ -72.03M	$ -155.01M	$ -135.34M	$ -82.15M
Investing Cash Flow	$ 0.00	$ 0.00	$ -20.00K	$ -139.00K	$ -445.00K
Financing Cash Flow	$ 56.52M	$ 36.66M	$ 26.52M	$ 96.24M	$ 102.45M
End Cash Position	$ 28.76M	$ 29.85M	$ 65.22M	$ 193.72M	$ 232.97M
Free Cash Flow	$ -57.62M	$ -72.03M	$ -155.03M	$ -135.48M	$ -82.60M

Currency in USD